Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Shock, Cardiogenic

• A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
• Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
• Cardiac Power Output in Cardiogenic Shock Patients
• Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
• Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support
• Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
• CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
• Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
• Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock: a Phase 0 Trial.
• Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock
• LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients
• The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
• Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output
• Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
• Adrecizumab in Cardiogenic Shock
• Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
• Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
• Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock
• Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine
• Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock
• Milrinone Versus Dobutamine in Critically Ill Patients
• Synchronized Cardiac Assist for Cardiogenic Shock
• GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
• Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock
• Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock
• Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock
• Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation
• HEROIC (Heparin Requirement in Counterpulsation)
• Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
• Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.
• A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
• Levosimendan Versus Dobutamine in Shock Patients
• Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.